No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / administration & dosage*
-
Adrenergic beta-Antagonists / adverse effects
-
Adrenergic beta-Antagonists / economics
-
Age Factors
-
Aged, 80 and over
-
Anticoagulants / administration & dosage*
-
Anticoagulants / adverse effects
-
Anticoagulants / economics
-
Atrial Fibrillation / diagnosis
-
Atrial Fibrillation / drug therapy*
-
Clinical Decision-Making
-
Electrocardiography
-
Factor Xa Inhibitors / administration & dosage*
-
Factor Xa Inhibitors / adverse effects
-
Factor Xa Inhibitors / economics
-
Humans
-
Male
-
Risk Factors
Substances
-
Adrenergic beta-Antagonists
-
Anticoagulants
-
Factor Xa Inhibitors